Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost-Reference-Cited by-同舟云学术

Long term results of a phase II trial of hypofractionated adjuvant radiotherapy for early-stage breast cancer with volumetric modulated arc therapy and simultaneous integrated boost

Published:2021-11 Issue: Volume:164 Page:50-56
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Franceschini D.,Fogliata A.^ORCID,Spoto R.,Dominici L.,Lo Faro L.,Franzese C.,Comito T.,Lobefalo F.,Reggiori G.,Cozzi L.,Sagona A.,Gentile D.,Scorsetti M.

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference30 articles.

1. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021

2. NCCN guidelines Version 1.2021.

3. Long-term results of hypofractionated radiation therapy for breast cancer;Whelan;N Engl J Med,2010

4. Effect of radiotherapy fraction size on tumour control in patients with early-stage breast cancer after local tumour excision: Long-term results of a randomised trial;Owen;Lancet Oncol,2006

5. The UK Standardisation of Breast Radiotherapy (START) Trial A of radiotherapy hypofractionation for treatment of early breast cancer: a randomised trial;START Trialists’ Group;Lancet Oncol,2008

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel x-Ray and γ-Ray combination strategy for radiotherapy after breast-conserving surgery in patients with right breast cancer;Frontiers in Oncology;2024-08-21

2. Intensity Modulated Therapy for Patients With Breast Cancer. Practical Guidelines and Tips for an Effective Treatment Planning Strategy;Advances in Radiation Oncology;2024-08

3. High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial;The Lancet Respiratory Medicine;2024-08

4. Simultaneous integrated boost intensity-modulated radiotherapy post breast-conserving surgery: clinical efficacy, adverse effects, and cosmetic outcomes in breast cancer patients;Breast Cancer;2024-05-05

5. Methodological guide for assessing the carbon footprint of external beam radiotherapy: A single-center study with quantified mitigation strategies;Clinical and Translational Radiation Oncology;2024-05